🇺🇸 FDA
Pipeline program

intravenous NAC

IRB#2006.212.A

Approved small_molecule active

Quick answer

intravenous NAC for Nephropathy is a Approved program (small_molecule) at CUMBERLAND PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
CUMBERLAND PHARMACEUTICALS INC
Indication
Nephropathy
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials